CIK 0001533743 · <br>Emerging growth company
Processa Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PCSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 451539785
- Phone
- 443-776-3133
- Business address
- 601 21ST STREET, SUITE 300, VERO BEACH, FL, 32960
- Former names
- Heatwurx, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-01 | Yorke Justin W Director | Grant or award · Stock Options (Right to Buy) | +300,000 | 300,000 | ||
| 2025-10-01 | Guy Wendy Chief Administrative Officer | Grant or award · Restricted Stock Units | +50,000 | 50,000 | ||
| 2025-10-01 | Guy Wendy Chief Administrative Officer | Grant or award · Stock Options (Right to Buy) | +150,000 | 150,000 | ||
| 2025-10-01 | Lin Patrick Chief Business - Strategy Off | Grant or award · Restricted Stock Units | +68,000 | 68,000 | ||
| 2025-10-01 | Lin Patrick Chief Business - Strategy Off | Grant or award · Stock Options (Right to Buy) | +204,000 | 204,000 | ||
| 2025-10-01 | Bigora Sian Chief Development Officer | Grant or award · Restricted Stock Units | +96,000 | 96,000 | ||
| 2025-10-01 | Bigora Sian Chief Development Officer | Grant or award · Stock Options (Right to Buy) | +288,000 | 288,000 | ||
| 2025-10-01 | SKIBSTED RUSSELL Chief Financial Officer | Grant or award · Restricted Stock Units | +108,000 | 108,000 | ||
| 2025-10-01 | SKIBSTED RUSSELL Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +324,000 | 324,000 | ||
| 2025-10-01 | Young David Pres. Research & Development | Grant or award · Restricted Stock Units | +111,000 | 111,000 | ||
| 2025-10-01 | Young David Pres. Research & Development | Grant or award · Stock Options (Right to Buy) | +333,000 | 333,000 | ||
| 2025-10-01 | Ng George K Chief Executive Officer | Grant or award · Restricted Stock Units | +256,000 | 256,000 | ||
| 2025-10-01 | Ng George K Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +768,000 | 768,000 | ||
| 2025-07-24 | Guy Wendy Chief Administrative Officer | Grant or award · Restricted Stock Units | +1,366,046 | 1,376,478 | ||
| 2025-07-24 | Lin Patrick Chief Business - Strategy Off | Grant or award · Restricted Stock Units | +1,401,650 | 1,412,082 | ||
| 2025-07-24 | Bigora Sian Chief Development Officer | Grant or award · Restricted Stock Units | +1,659,185 | 1,672,087 | ||
| 2025-07-24 | SKIBSTED RUSSELL Chief Financial Officer | Grant or award · Restricted Stock Units | +1,775,044 | 1,803,044 | ||
| 2025-07-24 | Young David Pres. Research & Development | Grant or award · Restricted Stock Units | +1,813,133 | 1,821,016 | ||
| 2025-07-24 | Ng George K Chief Executive Officer | Grant or award · Restricted Stock Units | +1,822,471 | 1,922,471 | ||
| 2025-07-24 | Neal James R Director | Grant or award · Restricted Stock | +175,299 | 206,505 |
Page 5 of 6 · 119 trades